Prognosis of Cerebral Small Vessel Disease (PRO-SVD)

Insel Gruppe AG, University Hospital Bern

Status: Enrolling

Conditions: CAA - Cerebral Amyloid Angiopathy; Small Vessel Cerebrovascular Disease; Cadasil; Cerebral Amyloid Angiopathy

Study type: Observational

Funder types: Other

Identifiers

NCT05734378

2020-02535

Details and patient eligibility

About

Prognosis of small vessel disease (SVD) depends on the underlying type of SVD and index manifestation.

The aim of this prospective, observational cohort study is to determine the risk of different outcome events among patients with SVD according to the type of index presentation.

Enrollment: 900 estimated patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hypertensive deep perforator arteriolopathy (DPA), clinically symptomatic with either ICH, ischaemic stroke, cognitive impairment or severe radiological manifestation (Fazekas ≥II)
• Cerebral amyloid angiopathy (CAA according to modified Boston or Edinburgh criteria), clinically symptomatic with either ICH (including cSAH), amyloid spells, cognitive impairment or severe radiological manifestation (CMB≥2)
• Other SVD (i.e. CADASIL or other sporadic or genetic SVD)

Exclusion criteria

• Life expectancy of <6 months due to not-SVD related causes (i.e. cancer)
• Patient is unlikely to attend follow-up visits